Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

0.7606
-0.0432-5.37%
Post-market: 0.77930.0187+2.46%19:57 EDT
Volume:1.12M
Turnover:880.56K
Market Cap:23.81M
PE:-0.24
High:0.8330
Open:0.8000
Low:0.7510
Close:0.8038
52wk High:5.25
52wk Low:0.7365
Shares:31.31M
Float Shares:26.89M
Volume Ratio:0.80
T/O Rate:4.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1505
EPS(LYR):-5.7255
ROE:-1766.94%
ROA:-102.43%
PB:-0.21
PE(LYR):-0.13

Loading ...

Jun 29, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
May 01, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 20, 2023

Major Issues Report

8-K - Current report
Apr 04, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report